INO-A002
/ Inovio
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
November 08, 2022
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1 | N=30 | Completed | Sponsor: University of Pennsylvania | Active, not recruiting ➔ Completed
Trial completion • Dengue Fever • CD4
October 19, 2021
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1; N=30; Active, not recruiting; Sponsor: University of Pennsylvania; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Dengue Fever • CD4
August 18, 2021
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1; N=30; Recruiting; Sponsor: University of Pennsylvania; Trial completion date: Feb 2023 ➔ Oct 2022; Trial primary completion date: Feb 2023 ➔ Oct 2022
Clinical • Trial completion date • Trial primary completion date • Dengue Fever • CD4
July 22, 2021
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1; N=30; Recruiting; Sponsor: University of Pennsylvania; Active, not recruiting ➔ Recruiting
Clinical • Enrollment open • Dengue Fever • CD4
March 11, 2021
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1; N=24; Active, not recruiting; Sponsor: University of Pennsylvania; Trial completion date: Feb 2021 ➔ Feb 2023; Trial primary completion date: Feb 2021 ➔ Feb 2023
Clinical • Trial completion date • Trial primary completion date • Dengue Fever • CD4
February 26, 2020
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
(clinicaltrials.gov)
- P1; N=24; Active, not recruiting; Sponsor: University of Pennsylvania; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed
1 to 6
Of
6
Go to page
1